Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer

High-grade non-muscle-invasive bladder cancer (HG NMIBC) patients are at high risk (HR) of progression to muscle-invasion. Bladder-preserving therapies for this patient subgroup are limited, and additional treatments are desirable. Recently, enfortumab vedotin, targeting cancer-associated NECTIN4, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Garczyk, Stefan, Degener, Stephan, Bischoff, Felix, Schnitzler, Tician, Salz, Anne, Golz, Reinhard, Buchner, Alexander, Schulz, Gerald B., Schneider, Ursula, Gaisa, Nadine T., Knüchel, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226103/
https://www.ncbi.nlm.nih.gov/pubmed/35484425
http://dx.doi.org/10.1007/s00428-022-03328-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226103/
https://www.ncbi.nlm.nih.gov/pubmed/35484425
http://dx.doi.org/10.1007/s00428-022-03328-1

Ejemplares similares